Abstract-The biological activity of a Habu (Trimeresurus flavoiridis) venom fraction with drug-metabolizing enzyme inhibitory action was studied. The venom fraction, which was isolated through Sephadex G-100 gel filtration and cation exchange chromatography on Amberlite CG50, caused an increase of vascular permeability and hemorrhage, but these actions were lost after heating at 70°C for 5 min. The fraction showed anticoagulant activity on citrated blood, and this activity remained after heating of the venom.
Abstract-The biological activity of a Habu (Trimeresurus flavoiridis) venom fraction with drug-metabolizing enzyme inhibitory action was studied. The venom fraction, which was isolated through Sephadex G-100 gel filtration and cation exchange chromatography on Amberlite CG50, caused an increase of vascular permeability and hemorrhage, but these actions were lost after heating at 70°C for 5 min. The fraction showed anticoagulant activity on citrated blood, and this activity remained after heating of the venom.
Guinea pig ileum was contracted by treatment with nonheated or heated venom fraction, and these contractions were inhibited with atropine and potentiated with physostigmine. These results suggest that the drug-metabolizing enzyme inhibitor isolated from Habu venom involves the heat stable component with anticoagulant activity and smooth muscle contractile action.
Habu snake (Trimeresurus flavoviridis) venom inhibits hepatic microsomal drug metabolizing enzymes under both in vitro and in vivo conditions, and the drug metabolizing enzyme inhibitor has been isolated from the venom (1 ). This inhibitor is heat stable and is separated from phos pholipase and arginine ester hydrolase which are known to be heat stable enzymes (2, 3) . The inhibitor also contains a hemorrhagic activity which is lost after heating. In SDS polyacrylamide gel electrophoresis, the in hibitor, even after heating, shows one protein band. Thus it has been unsettled whether the heat stable component included in the drug metabolizing enzyme inhibitor shows bio logical activity other than drug-metabolizing enzyme inhibitory action. The present study was conducted to clarify the biological activity of the heat stable component included in the inhibitor. (4) . Vascular permeability of the venom fraction was observed with rabbits. Evans Blue (20 mg in 1 ml of isotonic sodium chloride solution) was given into ear vein of a rabbit followed by an intracutaneous injection of 0.1 ml venom fraction into depilated back skin. The rabbit was killed with ether 2 hr after the venom injection, and the skin was removed. Blue spots caused by injection of venom fractions were observed from the visceral side of the removed skin. Smooth muscle contractive action was examined with the ileum removed from guinea pig according to the method of Ishida et al. (5) . Unless mentioned, the ileum preparation was changed in every experiment because of tachphylaxis caused by repeated use. The effect of the isolated venom fraction on blood coagulation was studied by measuring the time for fibrin formation with citrated blood. Five ml of blood taken from the jugular vein of a dog under anesthesia with pentobarbital was added into the test tube containing 0.5 ml of 3.8% sodium citrate. The resultant supernatant of citrated blood after centrifugation at 3000 rpm for 1 5 min was allowed to settle in a water bath at 37°C for 10 min. The venom fraction (0.2 ml) of varing concentrations was mixed with 1.0 ml of citrated blood followed by addition of 0.5 ml of 0.025 M calcium chloride solution.
Materials and Methods

Materials
Coagulant activity was measured by examining fibrin formation of the blood mixture. In the whole blood, the venom fraction of 0.1 ml was mixed with 1.0 ml of fresh blood, and the clotting time was measured. Isotonic sodium chloride solution was used as the control instead of the venom fraction.
The activity of phospholipase, proteinase or arginine ester hydrolase was measured according to the method described in the previous report (1 ) . Protein concen tration of the venom fraction was measured by the method of Lowry et al. (6) . Amino pyrine N-demethylase activity was measured as described in the previous report (1). 
Results
The venom fraction with drug-metabolizing enzyme inhibitory action (RRCG50) was 1.7% of the crude venom, and one-fourth of the fraction was heat stable (HRRCG50). Before and after heating, the fraction showed one protein band on SDS-polyacrylamide gel electrophoresis with a molecular weight of 27,500.
Both phospholipase and arginine ester hydrolase activities were not detected in the inhibitory fraction, while proteinase activity was scarcely observed. The fraction decreased aminopyrine N-demethylase activity to 60% in vivo. Figures 1 and 2 showed the effect of the inhibitor on vascular permeability and hemorrhage. The inhibitor caused hemorrhage and increase of vascular permeability, but these effects of the venom were completely lost after heating.
The coagulation times of citrated blood after addition of 6-7 ug of heated crude Habu venom, nonheated, and heated purified drug metabolizing enzyme inhibitor were 15, 22 and 26 min, respectively, while the control time by adding isotonic sodium chloride solution was 3 min ( Purified venom fraction (RRCG50) or the heated fraction (HRRCG 50) was injected to rabbits and vascular permeability was measured as described in Materials and Methods. 1 : RRCG50 (60 ,ng/0.1 ml), 2: 1 /10 RRCG50, 3: HRRCG50 (15 ,cg/0.1 ml), 4: isotonic sodium chloride solution (0.1 ml). Fig. 3 . Effect of heated venom fraction on coagu lation of citrated blood. Each dose of the heated fraction (HRRCG50) was added to citrated blood, and the time for fibrin formation was measured as described in Materials and Methods. Fig. 4 . Action of purified fraction (RRCG50) on the isolated guinea pig ileum. Ileum contraction was measured as described in Materials and Methods. The venom fraction (RRCG50) was added cumula tively into the bath (left figure), and after washing of the ileum with Tyrode solution, the venom was again given by the same method (center figure). ACh: 10-8 g/ml acetylcholine, Atr: 10-7 g/ml atropine, V: 6, 11, 15X10-5 g/ml RRCG60. Fig . 5 . Action of purified fraction (RRCG50) on the isolated guinea pig ileum in the presence of physostigmine. Ach: 10-8 g/ml acetylcholine, Es: 10-7 g/ml physostigmine, v: 6, 11 X10-5 g/ml RRCG50. Fig. 6 . Action of heated fraction (HRRCG50) on the isolated guinea pig ileum. Ach: 10-8 g/ml acetylcholine, Es: 10-' g/ml physostigmine, Atr: 10-7 g/ml atropine, hv: 3, 4X10-5 g/ml HRRCG50, Discussion Drug-metabolizing enzyme inhibitor sep arated from Habu venom was similar to hemorrhagic principle 2 (HR 2) in the aspects of hemorrhagic activity, molecular weight, and a lack of other enzymatic activities such as phospholipase and pro teinase (7). However, Ohsaka (8) proposed that purified hemorrhagic principle did not have blood coagulant inhibitory action. Since he did not present detailed data about anticoagulant activity of the venom, it is difficult to compare his fraction with our fraction. This discrepancy may come in part from the difference of purification steps that we used, Amberlite CG-50 as cation ion exchanger while Ohsaka preferred Bio-Rex 70, and also from the difference of venom source since we used the venom from Habu collected from Okinawa Island whereas he collected the venom from Amami Ohshima Island. The heat stable component containing the inhibitory activity was one-fourth of the whole protein, and it was not separated by column chromatography.
Though the heated crude venom anticoagulant activity was not so strong, this may be due to involvement of the component with coagulant activity, thrombin like enzyme (3, 9) , which was separated from the drug-metabolizing en zyme inhibitory fraction (data not shown). It is reasonable that hemorrhagic and anti coagulant activities are included in the same fraction of the Habu venom, and the latter may aggravate hemorrhage by inhibition of hemostasis.
Anticoagulant principle has been separated from the snake venom of Agkistrodon acutus, Trimeresurus gramineus, and T, mucrosguamatus (10) (11) (12) . The former two of them are acidic glycoproteins, and the last one is phospholipase A. The drug metabolizing enzyme inhibitory fraction from Habu venom was a basic protein, and it had no phospholipase A activity. It is, therefore, clear that the fraction with anticoagulant activity isolated from the Habu venom is different from that of the other three venoms. Further studies to clarify the mechanism of anticoagulant activity of the Habu venom fraction are in progress.
The drug-metabolizing enzyme inhibitor from the Habu venom contracted guinea pig ileum, and the heat stable component included in the inhibitor also had the same effect on the smooth muscle. This con traction of guinea pig ileum by the inhibitor, also by the heat stable component, was decreased with atropine and was potentiated with physostigmine.
Thus it was suggested that the contraction of the ileum was due to an acetylcholine-like substance which might be released by the venom treatment. Atropine did not completely inhibit the ileum con traction;
therefore, other pharmacological mediators may be involved in the smooth muscle contraction. According to Ishida et Thus, it was clarified in this study that the heat stable protein included in the drug metabolizing enzyme inhibitor from Habu venom showed smooth muscle contraction of guinea pig ileum and anticoagulant activity on citrated blood.
